Drug Shortage Report for 5% DEXTROSE INJECTION, USP

Last updated on 2022-05-13 History
Report ID 150514
Drug Identification Number 00060348
Brand name 5% DEXTROSE INJECTION, USP
Common or Proper name 5% DEXTROSE INJECTION, USP
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 5G
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL (JB0048)
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-12-06
Actual start date 2021-12-06
Estimated end date 2022-05-31
Actual end date
Shortage status Actual shortage
Updated date 2022-05-13
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-05-13 French Compare
v10 2022-05-13 English Compare
v9 2022-04-12 French Compare
v8 2022-04-12 English Compare
v7 2022-03-24 French Compare
v6 2022-03-24 English Compare
v5 2022-02-14 French Compare
v4 2022-02-14 English Compare
v3 2021-12-07 English Compare
v2 2021-12-06 French Compare
v1 2021-12-06 English Compare

Showing 1 to 11 of 11